Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
SL4903 CAR-T(Hebei Senlangbio Biotechnology) in Multiple Myeloma: NCT07234721 Clinical Landscape Report 2026
15 October 2026
NCT07234721 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roflumilast in Psoriasis: NCT07233291 Clinical Landscape Report 2026
15 October 2026
NCT07233291 clinical landscape for Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CM512 in Dermatitis, Atopic: NCT07230483 Clinical Landscape Report 2026
15 October 2026
NCT07230483 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CT-0991 in Relapsing acute myeloid leukemia: NCT07233018 Clinical Landscape Report 2026
15 October 2026
NCT07233018 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Tapinarof in Psoriasis vulgaris: CTRI/2025/11/097658 Clinical Landscape Report 2026
15 October 2026
CTRI/2025/11/097658 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Locally Advanced Cervical Carcinoma: NCT07232654 Clinical Landscape Report 2026
15 October 2026
NCT07232654 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Fludarabine Phosphate in Acute Myeloid Leukemia: NCT07232953 Clinical Landscape Report 2026
15 October 2026
NCT07232953 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cytarabine in Acute Myeloid Leukemia: NCT07232134 Clinical Landscape Report 2026
15 October 2026
NCT07232134 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Allogeneic γδ T cell(Wuhan Xiehe Hospital Tower) in Acute Myeloid Leukemia: NCT07237230 Clinical Landscape Report 2026
15 October 2026
NCT07237230 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBT-001(Bambusa Therapeutics) in Dermatitis, Atopic: NCT07239947 Clinical Landscape Report 2026
15 October 2026
NCT07239947 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ZL-1503 in Dermatitis, Atopic: NCT07235384 Clinical Landscape Report 2026
15 October 2026
NCT07235384 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Abrocitinib in Alopecia Areata: NCT07242638 Clinical Landscape Report 2026
15 October 2026
NCT07242638 clinical landscape for Alopecia Areata: endpoints, sponsor, phase, geography, readouts, asset context and development white space.